Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Görgün, P. Yildiz, F. Secik, K. Midilli, V. Akkaya (Istanbul, Turkey). Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion. Eur Respir J 2013; 42: Suppl. 57, 1518

Member's Comments

No comment yet.

Related content which might interest you: Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Risk of occult pleural infection in patients with malignant effusions Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 What outcome after pleurodesis in malignant pleural effusion in lung cancer? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Malignant pleural effusion (MPE) as debut of cancer Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Malignant pleural effusion as the initial manifestation of gynecological malignancies Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016